These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21425752)

  • 41. A cancer gone viral.
    Mettner J
    Minn Med; 2011 Nov; 94(11):22-5. PubMed ID: 22413644
    [No Abstract]   [Full Text] [Related]  

  • 42. A review of prophylactic human papillomavirus vaccines: recommendations and monitoring in the US.
    Dunne EF; Datta SD; E Markowitz L
    Cancer; 2008 Nov; 113(10 Suppl):2995-3003. PubMed ID: 18980283
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The quadrivalent human papillomavirus vaccine.
    Wheat A
    Med Health R I; 2008 Dec; 91(12):387-9. PubMed ID: 19170317
    [No Abstract]   [Full Text] [Related]  

  • 44. Two new vaccines: Gardasil and Rotateq.
    Van Gilder D
    S D Med; 2007 Jan; 60(1):13-4. PubMed ID: 17319292
    [No Abstract]   [Full Text] [Related]  

  • 45. Prevention strategies against human papillomavirus in males.
    Garland SM
    Gynecol Oncol; 2010 May; 117(2 Suppl):S20-5. PubMed ID: 20138347
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine.
    Joura EA; Kjaer SK; Wheeler CM; Sigurdsson K; Iversen OE; Hernandez-Avila M; Perez G; Brown DR; Koutsky LA; Tay EH; García P; Ault KA; Garland SM; Leodolter S; Olsson SE; Tang GW; Ferris DG; Paavonen J; Lehtinen M; Steben M; Bosch X; Dillner J; Kurman RJ; Majewski S; Muñoz N; Myers ER; Villa LL; Taddeo FJ; Roberts C; Tadesse A; Bryan J; Lupinacci LC; Giacoletti KE; Lu S; Vuocolo S; Hesley TM; Haupt RM; Barr E
    Vaccine; 2008 Dec; 26(52):6844-51. PubMed ID: 18930097
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vaccine may decrease chances of oral cancer.
    Br Dent J; 2007 Sep; 203(6):299. PubMed ID: 17891076
    [No Abstract]   [Full Text] [Related]  

  • 48. Post-licensure monitoring of HPV vaccine in the United States.
    Markowitz LE; Hariri S; Unger ER; Saraiya M; Datta SD; Dunne EF
    Vaccine; 2010 Jul; 28(30):4731-7. PubMed ID: 20188681
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of baseline covariates on the immunogenicity of a quadrivalent (types 6, 11, 16, and 18) human papillomavirus virus-like-particle vaccine.
    Giuliano AR; Lazcano-Ponce E; Villa L; Nolan T; Marchant C; Radley D; Golm G; McCarroll K; Yu J; Esser MT; Vuocolo SC; Barr E
    J Infect Dis; 2007 Oct; 196(8):1153-62. PubMed ID: 17955433
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Squamous cell carcinoma of the oropharynx in Australian males induced by human papillomavirus vaccine targets.
    Hong AM; Grulich AE; Jones D; Lee CS; Garland SM; Dobbins TA; Clark JR; Harnett GB; Milross CG; O'Brien CJ; Rose BR
    Vaccine; 2010 Apr; 28(19):3269-72. PubMed ID: 20226244
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chapter 13: Current findings from prophylactic HPV vaccine trials.
    Koutsky LA; Harper DM
    Vaccine; 2006 Aug; 24 Suppl 3():S3/114-21. PubMed ID: 16949998
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CancerScope: FDA Advisory Committee supports second HPV vaccine.
    Printz C
    Cancer; 2009 Nov; 115(22):5130. PubMed ID: 19890873
    [No Abstract]   [Full Text] [Related]  

  • 53. Survey hints at uneven adoption of cancer vaccine.
    Boughton B
    Nat Med; 2008 Jan; 14(1):5. PubMed ID: 18180705
    [No Abstract]   [Full Text] [Related]  

  • 54. CancerScope: HPV vaccine for boys and men? It could help reduce incidence of cervical and head and neck cancers.
    Printz C
    Cancer; 2009 Nov; 115(22):5129-30. PubMed ID: 19890862
    [No Abstract]   [Full Text] [Related]  

  • 55. Clinical trial and post-licensure safety profile of a prophylactic human papillomavirus (types 6, 11, 16, and 18) l1 virus-like particle vaccine.
    Block SL; Brown DR; Chatterjee A; Gold MA; Sings HL; Meibohm A; Dana A; Haupt RM; Barr E; Tamms GM; Zhou H; Reisinger KS
    Pediatr Infect Dis J; 2010 Feb; 29(2):95-101. PubMed ID: 19952863
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases.
    Garland SM; Hernandez-Avila M; Wheeler CM; Perez G; Harper DM; Leodolter S; Tang GW; Ferris DG; Steben M; Bryan J; Taddeo FJ; Railkar R; Esser MT; Sings HL; Nelson M; Boslego J; Sattler C; Barr E; Koutsky LA;
    N Engl J Med; 2007 May; 356(19):1928-43. PubMed ID: 17494926
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quadrivalent human papillomavirus vaccine.
    Barr E; Tamms G
    Clin Infect Dis; 2007 Sep; 45(5):609-7. PubMed ID: 17682997
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proposed HPV vaccine mandates rile health experts across the country.
    Savage L
    J Natl Cancer Inst; 2007 May; 99(9):665-6. PubMed ID: 17470731
    [No Abstract]   [Full Text] [Related]  

  • 59. The case for HPV immunization.
    Campos-Outcalt D
    J Fam Pract; 2009 Dec; 58(12):660-4. PubMed ID: 19961821
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Protecting our patients from HPV and HPV-related diseases: the role of vaccines.
    Mahoney MC
    J Fam Pract; 2006 Nov; Suppl():10-7. PubMed ID: 17366753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.